Cargando…
P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431352/ http://dx.doi.org/10.1097/01.HS9.0000849796.83034.ba |
| _version_ | 1784780031069782016 |
|---|---|
| author | Kuo, K. H. Grace, R. F. van Beers, E. J. Barcellini, W. Glenthøj, A. Holzhauer, S. Patel, P. Beynon, V. Li, J. Zagadailov, E. Al-Samkari, H. |
| author_facet | Kuo, K. H. Grace, R. F. van Beers, E. J. Barcellini, W. Glenthøj, A. Holzhauer, S. Patel, P. Beynon, V. Li, J. Zagadailov, E. Al-Samkari, H. |
| author_sort | Kuo, K. H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431352 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313522022-08-31 P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL Kuo, K. H. Grace, R. F. van Beers, E. J. Barcellini, W. Glenthøj, A. Holzhauer, S. Patel, P. Beynon, V. Li, J. Zagadailov, E. Al-Samkari, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431352/ http://dx.doi.org/10.1097/01.HS9.0000849796.83034.ba Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kuo, K. H. Grace, R. F. van Beers, E. J. Barcellini, W. Glenthøj, A. Holzhauer, S. Patel, P. Beynon, V. Li, J. Zagadailov, E. Al-Samkari, H. P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL |
| title | P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL |
| title_full | P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL |
| title_fullStr | P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL |
| title_full_unstemmed | P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL |
| title_short | P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL |
| title_sort | p1735: improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency: a descriptive analysis from the phase 3 activate trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431352/ http://dx.doi.org/10.1097/01.HS9.0000849796.83034.ba |
| work_keys_str_mv | AT kuokh p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT gracerf p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT vanbeersej p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT barcelliniw p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT glenthøja p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT holzhauers p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT patelp p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT beynonv p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT lij p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT zagadailove p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial AT alsamkarih p1735improvementsinpatientreportedoutcomesinmitapivattreatedpatientswithpyruvatekinasedeficiencyadescriptiveanalysisfromthephase3activatetrial |